SPAC
Vesicor Therapeutics Is Going Public via SPAC — Here’s the Setup
Vesicor Therapeutics is a San Gabriel, California-based development-stage biotech going public via merger with Black Hawk Acquisition Corp (Nasdaq: BKHA). The deal gives retail investors a preclinical p53-cancer story at a $70 million equity value, but the setup still hinges on redemptions, financing, and whether the company can fund its next research steps.
Jul 1, 20267 MIN